USPTO serial 86809467
OPTIFORM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 28, 2016
- Examiner
- CROWLEY, SEAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OPTIFORM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
CATALENT PHARMA SOLUTIONS, INC.
Somerset, NJ, US
CATALENT PHARMA SOLUTIONS, INC.
Somerset, NJ, US
CATALENT PHARMA SOLUTIONS, INC.
Bridgewater, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Vanessa A. Ignacio, Esq.
Vanessa A. Ignacio, Esq. LOWENSTEIN SANDLER LLPOne Lowenstein DriveROSELAND, NJ 07068United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific research services; Chemical compound and chemical compound library research and development services; Pharmaceutical research and development, namely, screening drug targets; Pharmaceutical research and development, namely, automated screening of pharmaceutical and chemical compounds; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of oral dose drug development; Conducting scientific feasibility studies; Pharmaceutical research services, namely, screening and identifying optimal active pharmaceutical ingredient (API) forms, optimized final dosing forms, dosing profiles, optimal formulation of pharmaceutical products, determination of drug substance state for enhanced bioavailability, ingredient compatibility screening, solid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product development, optimization of optimal active pharmaceutical ingredient (API) design, formulation of pharmaceutical products and drug product design | ACTIVE | Aug 9, 2010 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks owned by CATALENT PHARMA SOLUTIONS, INC.
- Other trademarks in Class 042
- Similar marks named OPTIFORM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 12, 2026 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Aug 12, 2026 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Aug 12, 2026 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Aug 12, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 15, 2026 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jun 28, 2025 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Dec 25, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 13, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jan 13, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 13, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 28, 2022 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jun 28, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 22, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 28, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 7, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 26, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 10, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Nov 9, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2015 | NWAP | NEW APPLICATION ENTERED | — |